Session 8: Hormone Considerations in Transgender Patients with Gynecologic Cancer


Panelists:
Allison Asante, PA-C, MBA
Ishani, Choksi, MD
Minghao Liu, MD
Bobbie J. Rimel, MD (moderator)
 

Recorded on July 18, 2022.

Target Audience

HealthCare Providers, Physicians, Trainees, APPs, Fellows, Residents, Pharmacists, Nurses, Office Staff

Learning Objectives

  • Review the general standards of what’s “normal” in cross-gender hormone therapy patients with an endocrinologist
  • Explore risks and benefits of cross-gender hormones to consider if a transgender patient elects to use them
  • Discuss how to counsel a patient about hormone therapy before and during cancer treatment with a gynecologic oncologist

Additional Information

AttachmentSize
PDF icon SGO 7.25.22 Mod 8 Enduring-LN.pdf151.37 KB
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
07/22/2022
Course expires: 
12/31/2025
Cost:
$0.00
Part of: 
Welcoming Spaces: Treating Your LGBTQ+ Patients
Rating: 
0

Session 8 of this series is no longer offering CE.

Available Credit

  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.